A Whiff of Tax­on­omy – Eliobac­ter woosyi

by the STC team

We have the great plea­sure to in­form you, our Read­ers, that a team of mi­cro­bi­ol­o­gists has privi­leged us with a peek into a draft of the first for­mal de­scrip­tion ever of­fered of a par­tic­u­lar bac­te­ri­um that has puz­zled mi­cro­bi­ol­o­gists for al­most a cen­tury. For the bac­terium, they pro­pose the na­me Eliobac­ter woosyi, and as they can grow it in the lab on de­fined me­dia there's no need for a "Can­di­da­tus" pre­fix. The bac­terium was first iso­lated in the 1920s in an ob­scure butch­ery in an un­named town in south­east Poland, and by un­known cir­cum­stances made it into the strain col­lect­ion of the Mi­cro­bi­ol­ogy Dept. at Uni­ver­si­dad Cen­tral del Ecuador, Quito. While Gram-stain­ing gave re­pro­ducibly am­bigu­ous re­sults, it was most com­monly de­scribed as Gram-neg­a­tive in the few sur­viv­ing notes and re­ports of the sci­en­tists who first worked with it (an en­try in Bergey's Man­ual is still miss­ing though). The bac­terium grows as straight, elon­gated rods, which are prob­a­bly mo­tile, though fla­gella have never been ob­served. Early re­ports from Quito make men­tion of the ra­ther un­usual po­lar fim­briae, lo­cated ex­clu­sively at one cell pole in the form of a "per­illa" (quo­ta­tion marks in the orig­i­nal re­port; per­illa trans­lates to goa­tee). More re­cent re­ports de­scribe the cells of Eliobac­ter woosyi  as slightly curved rods, but this might be a con­se­quence of pro­longed cul­ti­va­tion in the lab and not the orig­i­nal phe­no­type. How­ever, the newer re­ports are con­sis­tent with ear­lier re­ports in their men­tion of the "goatee"-type of po­lar fim­briae. Growth tests demon­strated that Eliobac­ter woosyi  is a mesophilic het­erotroph that ac­cepts more than a dozen dif­fer­ent su­gars as C‑source, but grows poorly on starch, and not at all on cel­lu­lose. It can grow on sugar-sup­­ple­mented min­i­mal me­dia con­tain­ing up to ~5% (w/v) ethanol, but ethanol is ap­par­ently not meta­bo­lized (sus­pi­ciously, the re­ports don't men­tion the method by which this was mea­sured). Most strik­ing, how­ever, is the ob­ser­va­tion al­ready men­tioned in re­ports from Quito, dated c. 1944, that Eliobac­ter woosyi  thrives in the pres­ence of cu­ri­omycin at con­cen­tra­tions rang­ing from 4 µM to mil­limo­lar. This is note­wor­thy as most bac­te­ria are in­her­ently re­sis­tant to cu­ri­omycin (>10 mM!), and the few that were shown to be sus­cep­ti­ble de­velop de­pen­dency rather than re­sis­tance within a few gen­er­a­tions (the loci re­spon­si­ble re­main to be elu­ci­dated; Luigi Gorini's at­tempts to map them were un­suc­cess­ful).

Cell of Eliobac­ter woosyi  shortly af­ter trans­fer from mi­nimal medium to BHI medium. Accor­ding to the au­thors, the color change ob­served in the cen­ter of the cell is due to the change of the medium and no sign of com­menc­ing cell di­vi­sion (stain­ing method not speci­fied). Source

The de­tails of the growth phys­i­ol­ogy of Eli­cobac­ter woo­syi  were so dif­fi­cult to work out that our col­leagues said it gave them a headache and they couldn't do any bet­ter than the Copen­hagen School. The cells grow slowly but, upon trans­fer into fresh medium, show no signs of a lag phase and only en­ter into sta­tion­ary phase when curio­my­cin is omit­ted. Since the cells grow so slowly, a true 'ex­po­nen­tial growth phase' could not be de­fined (they tried with semi-log pa­per but to no avail). They no­ticed dur­ing re­cent growth tests, how­ever, that trans­fer of cells from min­i­mal medium to solid or liq­uid brain-heart-in­fu­­sion me­dia (BHI) greatly stim­u­lated the growth of Elio­bac­ter woosyi  but, in­ter­est­ingly, only in the pres­ence of cu­rio­mycin.

Eliobac­ter woosyi  is, in all like­li­hood, non-path­o­genic. There ex­ists an ob­scure, pre­vi­ously sup­pressed re­port from the Wal­ter Reed Gen­eral Hos­pi­tal, dat­ing from the end of WW2, that men­tions out­bursts of Rick­ettsia in­fect­ions among staffers. A con­tem­po­rary wit­ness, how­ever, sus­pected Eliobac­ter woosyi  as the ac­tual cul­prit, not­ing that in most cases the in­fec­tion was be­nign, yet tended to be­come chronic read­ily (which made Rick­ettsia an un­likely source). An­other al­leged, i.e., badly doc­u­mented, out­burst of an in­fec­tion among the staff and stu­dents of the Med­ical School at Tufts Uni­ver­sity, Boston, MA, in the 1970s has also been at­trib­uted to E. woosyi, but clear ev­i­dence is lack­ing. Well doc­u­mented, on the other hand, is the pro­fi­ciency of E. woosyi  to per­sist in a pro­lif­er­a­tion-com­pe­tent state on the in­ter­net. To­gether with a few other bac­te­ria (and as­so­ci­ated bac­te­rio­phages) that are gen­er­ally known for their plank­tonic lifestyle, E. woosyi  was re­peat­edly found as the ma­jor com­po­nent of a gooey biofilm at the fringes of the in­ter­net that, be­cause of its per­sis­tence, has been dubbed the 'STC' (for: Story-Telling-Con­sor­tium). In­ter­est­ingly, within this con­sor­tium, E. woosyi  ap­par­ently thrives in the ab­sence of cu­ri­omycin.

The fore­go­ing nar­ra­tive was com­piled af­ter ex­ten­sive stud­ies by Christoph. Merry's re­ac­tion was as fol­lows: Christoph's analy­sis re­veals his deep-seated knowl­edge of the his­tory of the field as per­tains in par­tic­u­lar to this unique or­gan­ism. He has now sub­mit­ted the ini­tial find­ings as a Let­ter to STC for the usual peer re­view process. Should we rec­om­mend ac­cep­tance and pub­li­ca­tion? This re­viewer con­sid­ers the find­ings to be very well re­searched and pre­sented, but ques­tions re­main. Would the bac­terium in ques­tion mod­estly pre­fer to not be the sub­ject of a post on this re­spected blog? Would such a post re­quire an­no­ta­tion ex­plain­ing some of the de­tails, such as the BHI me­di­um, de­tails that re­veal in­ti­mate se­crets of the growth strat­egy of this species? Other ref­er­ences to the evo­lu­tion of E. woosyi  may not be mean­ing­ful to most read­ers. My ini­tial re­sponse is that this let­ter would best be cir­cu­lated among other mem­bers of the con­sor­tium, but may not thrive if in­troduced into a dif­fer­ent ecosys­tem.

To which Roberto replied: My re­sponse to the re­sponse is that fur­ther mean­ing can be gleaned through ex­ten­sive di­a­logue in the com­ments sec­tion, some­thing that will most cer­tainly in­crease the meta­bolic rates of E. woosyi. In sum­mary, I strongly rec­om­mend ac­cep­tance and pub­li­ca­tion on this very spe­cial date. Also it should be noted that E. woosyi is not the type species for this ge­nus. In re­sponse, Christoph noted that the NCBI tax­on­omy web­page has no en­tries for 'Eliobac­ter' so we're free to choose a type species. Any sug­ges­tions ? Merry replied with two: Eliobac­ter ele­gans ? Eliobac­ter scrip­tus ? Jamie sug­gested Eliobac­ter qua­si­bov­i­nus  (some­times known as "Qua­si­­­moo-do"). But there is a sin­gle strain de­scribed for that species and it re­mains quite ob­scure. So the fi­nal con­sen­sus of the STC team was to stick with Eliobac­ter woosyi as the rep­re­sen­ta­tive spe­cies. Un­for­tu­nately, the phyletic po­si­tion­ing of the Eliobac­ter­aceae is pretty con­fus­ing, and at pre­sent their SRU sig­na­ture would point to "un­clas­si­fied gammapro­teobac­te­ria", which is sort of a junk drawer for all these bugs that we know so lit­tle about (their oriC s look pretty con­ven­tional though).

Late in the re­view process, Daniel com­mented: I would like to men­tion some re­cent un­pub­lished re­sults on Eliobac­ter woosyi  from my lab done in col­lab­o­ra­tion with an evo­lu­tion­ary ecol­o­gist. Al­though pre­lim­i­nary, I thought they'd be rel­e­vant. We've be­come in­ter­ested in the mys­ter­ies sur­rounding E. woosyi  iso­la­tion from the en­vi­ron­ment. Though widely cul­ti­vated in the lab, anec­do­tes from re­searchers hold that the species is be­com­ing in­creas­ingly dif­fi­cult to iso­late from the en­vi­ron­ment. This has spurred con­cerns, first re­gard­ing the fu­ture of study­ing how the domes­ti­ca­ted lab­o­ra­tory strain may dif­fer from the feral an­ces­tor. For in­stance, spec­u­la­tions in­clude that an­ces­tral pop­u­la­tions of E. woosyi  may be less di­verse in cell sig­nal­ing (com­mu­ni­ca­tion) mole­cul­es, al­low­ing it to only 'talk' with a lim­ited au­di­ence of its own na­tive pop­u­la­tion. An­other more se­ri­ous con­cern is whether environ­mental E. woosyi  is go­ing ex­tinct or turn­ing un­cul­tur­able due to pop­u­la­tion shifts mak­ing it more fas­tid­i­ous. We there­fore started a project to look at changes in E. woosyi's  genome through the years be­tween the few environ­mental iso­lates that have been ob­tained. Ad­di­tion­ally we made nu­mer­ous at­tempts to recul­ture the species from the environ­ment or de­tect the pres­ence of its genome within var­i­ous en­vi­ron­men­tal sam­ples. Sadly our data sug­gests that E. woosyi  is grad­u­ally van­ish­ing from the wild, with mu­ta­tions build­ing up that limit the cells' ca­pa­bil­ity to di­vide. The rea­son for the evo­lu­tion of this char­ac­ter­is­tic in global popula­tions is un­clear. How­ever, the good news is that this wan­ing of E. woosyi  in the en­vi­ron­ment ap­pears to cor­re­late with a dras­tic du­pli­ca­tion and up­reg­u­la­tion in genes in­volved in hor­i­zon­tal gene trans­fer. We cur­rently fa­vor a model where E. woosyi, though it may even­tu­ally dis­ap­pear from the en­vi­ron­ment, has evolved to pass on in­te­gral parts of its ge­netic iden­tity to other species. We have be­gun char­ac­ter­iz­ing a few such cases, specif­i­cally where E. woosyi  seems to have passed the gene for cu­ri­omycin uti­liza­tion to other species, greatly stim­u­lat­ing their growth in the pre­sen­ce of the drug, en­abling them to out­com­pete com­peti­tors. We be­lieve this ar­gues that E. woosyi's  lifestyle has led to the ben­e­fit of many other bac­te­r­ial species and will al­low defin­ing as­pects of its unique genome to live on in mi­cro­bial com­mu­ni­ties for bil­lions of bil­lions of bac­te­r­ial gen­er­a­tions to come.

When all the dis­cus­sion was over, the STC team unan­i­mously agreed to pub­lish this Let­ter. Con­si­de­r­ing that few mi­cro­bial species have so pro­foundly in­flu­enced their en­vi­ro­ments as Eliobac­ter woosyi  has, the team en­thu­si­as­ti­cally ap­proved Roberto's sug­ges­tion that April 25th be recog­ni­zed uni­ver­sally as "Eliobac­ter Cel­e­bra­tion Day." Happy Birth­day Elio!

 

Other Posts